A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Clinical trial NCT04238819 · COMPLETED
Trial details
- NCT number
- NCT04238819
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2024-03-15
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.